Suppr超能文献

观点:胺碘酮会增加非猝死性死亡吗?如果是,原因是什么?

Perspectives: does amiodarone increase non-sudden deaths? If so, why?

作者信息

Auricchio A, Nisam S, Klein H U

机构信息

Department of Cardiology, University Hospital, Magdeburg, Germany.

出版信息

J Interv Card Electrophysiol. 2000 Dec;4(4):569-74. doi: 10.1023/a:1026505329169.

Abstract

Despite the antiarrhythmic efficacy of amiodarone, a definitive correlation between amiodarone treatment and increased non-arrhythmic mortality in patients with heart failure and depressed ventricular function has been reported. Results from research in the field of cardiac resynchronization therapy in heart failure may provide some explanations to this observation. We discussed the hypothetical link between amiodarone and non-arrhythmic mortality, which might have a cause--effect relationship, based on cardiac electromechanical disarrangement provoked by electrophysiological properties of amiodarone.

摘要

尽管胺碘酮具有抗心律失常疗效,但已有报道称,在心力衰竭且心室功能降低的患者中,胺碘酮治疗与非心律失常性死亡率增加之间存在明确关联。心力衰竭心脏再同步治疗领域的研究结果可能为这一观察结果提供一些解释。我们基于胺碘酮的电生理特性引发的心脏机电紊乱,讨论了胺碘酮与非心律失常性死亡率之间可能存在因果关系的假设联系。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验